NDC Package 0173-0695-04 Advair Diskus

Fluticasone Propionate And Salmeterol Powder Respiratory (inhalation) - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0173-0695-04
Package Description:
1 INHALER in 1 CARTON / 14 POWDER in 1 INHALER
Product Code:
Proprietary Name:
Advair Diskus
Non-Proprietary Name:
Fluticasone Propionate And Salmeterol
Substance Name:
Fluticasone Propionate; Salmeterol Xinafoate
Usage Information:
This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.
11-Digit NDC Billing Format:
00173069504
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 896161 - fluticasone propionate/salmeterol 100/50 MCG/INHAL Dry Powder Inhaler, 14 Blisters
  • RxCUI: 896161 - 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler
  • RxCUI: 896161 - fluticasone propionate 0.1 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 14 ACTUAT
  • RxCUI: 896161 - fluticasone propionate 100 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 14 ACTUAT
  • RxCUI: 896165 - ADVAIR DISKUS 100/50 MCG/INHAL Dry Powder Inhaler, 14 Blisters
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Glaxosmithkline Llc
    Dosage Form:
    Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
    Administration Route(s):
  • Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
  • Sample Package:
    No
    FDA Application Number:
    NDA021077
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    02-28-2001
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0173-0695-001 INHALER in 1 CARTON / 60 POWDER in 1 INHALER

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0173-0695-04?

    The NDC Packaged Code 0173-0695-04 is assigned to a package of 1 inhaler in 1 carton / 14 powder in 1 inhaler of Advair Diskus, a human prescription drug labeled by Glaxosmithkline Llc. The product's dosage form is powder and is administered via respiratory (inhalation) form.

    Is NDC 0173-0695 included in the NDC Directory?

    Yes, Advair Diskus with product code 0173-0695 is active and included in the NDC Directory. The product was first marketed by Glaxosmithkline Llc on February 28, 2001 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0173-0695-04?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 0173-0695-04?

    The 11-digit format is 00173069504. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20173-0695-045-4-200173-0695-04